KROS Keros Therapeutics, Inc. - common stock
$10.86
Price · Aug 19, 2026
Fundamentals as of Aug 3, 2026
52W Range
$10–$23
9% of range
Analyst Rating
BUY
14 analysts
Price Target
$20
+83% upside
P/E (TTM)
4.7
ROE
17.2%
Net Profit Margin
35.7%
KROS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$10.86
Market Cap
$212M
P/E (TTM)
4.7
EPS (TTM)
$2.30
Revenue (TTM)
$244M
Div Yield
—
ROE
17.2%
Debt/Equity
—
52W Range
$10 – $23
KROS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$244M
2019-12-31
→
2025-12-31
EPS
$2.30
2020-12-31
→
2025-12-31
Free Cash Flow
$106M
2020-12-31
→
2025-12-31
Margins
35.7%
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
KROS
Peer Median
P/E (TTM)
4.7
1.2
P/S (TTM)
0.9
6.3
P/B
0.7
1.6
Price / FCF
2.0
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
KROS
Peer Median
Operating Margin
27.7%
—
Net Profit Margin
35.7%
-312.6%
ROA
18.2%
-56.8%
ROE
17.2%
-83.3%
ROIC
21.1%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
KROS
Peer Median
Current Ratio
15.5
8.5
Quick Ratio
14.3
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
KROS
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
KROS
Peer Median
KROS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
14 analysts
- Strong Buy 3 21.4%
- Buy 6 42.9%
- Hold 5 35.7%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
6 analysts · 2026-08-18
Median
$19.00
Mean
$19.83
← Below all targets
$10.86
Low
$16.00
High
$25.00
Median target
$19.00
+75.0%
Mean target
$19.83
+82.6%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.78%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $-1.45 | $-1.37 | -0.08% |
| March 31, 2026 | $-1.21 | $-1.04 | -0.17% |
| Dec. 31, 2025 | $-0.86 | $-0.64 | -0.22% |
| Sept. 30, 2025 | $-0.18 | $-1.07 | 0.89% |
| June 30, 2025 | $-0.76 | $-1.15 | 0.39% |
| March 31, 2025 | $3.62 | $-0.25 | 3.9% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| KROS | $398M | 8.9 | — | 35.7% | 17.2% | — |
| IMUX | — | -0.9 | — | — | — | — |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | — |
| NBP | — | — | — | — | — | — |
| ABOS | $128M | -1.1 | — | — | -129.4% | — |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | — |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | — |
| PEPG | $448M | -3.1 | — | — | -82.0% | — |
| CHRS | $172M | 1.0 | 59.8% | 398.4% | 185.8% | — |
| HUMA | — | — | — | — | — | — |
| CRBP | $143M | -1.4 | — | — | -60.8% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 14
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $244M | $0 | $151.0K | $0 | $20M | $0 | $10M | |
| R&D Expense | $130M | $174M | $135M | $87M | $55M | $34M | $17M | |
| SG&A Expense | $47M | $41M | $35M | $28M | $21M | $13M | $3M | |
| Operating Expenses | $176M | $214M | $170M | $115M | $76M | $47M | $21M | |
| Operating Income | $68M | $-211M | $-170M | $-115M | $-56M | $-47M | $-11M | |
| Other Non-op | $-539.0K | $-954.0K | $-206.0K | $-613.0K | $-383.0K | $160.0K | $241.0K | |
| Pretax Income | $92M | $-187M | $-153M | $-105M | $-57M | $-46M | $-12M | |
| Income Tax | $5M | $300.0K | $0 | $0 | $2M | $-172.0K | $0 | |
| Net Income | $87M | $-187M | $-153M | $-105M | $-59M | $-45M | $-12M | |
| EPS (Basic) | $2.34 | $-5.00 | $-5.20 | $-4.15 | $-2.52 | $-2.93 | · | |
| EPS (Diluted) | $2.30 | $-5.00 | $-5.20 | $-4.15 | $-2.52 | $-2.93 | · | |
| Shares (Basic) | 37,221,211 | 37,437,652 | 29,447,119 | 25,241,030 | 23,333,914 | 15,506,397 | · | |
| Shares (Diluted) | 37,859,106 | 37,437,652 | 29,447,119 | 25,241,030 | 23,333,914 | 15,506,397 | · | |
| EBITDA | $68M | $-211M | $-170M | $-115M | $-56M | $-47M | · |
Balance Sheet 23
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $287M | $560M | $331M | $279M | $230M | $266M | $7M | |
| Receivables | $4M | $3M | $143.0K | $0 | $18M | $0 | · | |
| Prepaid Expense | $22M | $26M | $16M | $7M | $3M | $2M | $381.0K | |
| Other Current Assets | $2M | $1M | $1M | $276.0K | $210.0K | $160.0K | $215.0K | |
| Current Assets | $315M | $589M | $347M | $286M | $251M | $268M | $9M | |
| PP&E (Net) | $4M | $4M | $4M | $2M | $1M | $724.0K | $708.0K | |
| PP&E (Gross) | $9M | $7M | $6M | $3M | $2M | $1M | $1M | |
| Accum. Depreciation | $4M | $3M | $2M | $1M | $846.0K | $721.0K | $453.0K | |
| Other Non-current Assets | $0 | $2M | $2M | $2M | $82.0K | $0 | · | |
| Total Assets | $338M | $616M | $370M | $307M | $255M | $269M | $11M | |
| Accounts Payable | $2M | $5M | $5M | $3M | $4M | $2M | $2M | |
| Accrued Liabilities | $16M | $21M | $18M | $13M | $7M | $5M | $2M | |
| Current Liabilities | $20M | $27M | $24M | $17M | $12M | $7M | $4M | |
| Capital Leases | $14M | $17M | $13M | $13M | $231.0K | $476.0K | $899.0K | |
| Other Non-current Liabilities | · | · | · | · | $0 | $62.0K | $119.0K | |
| Total Liabilities | $35M | $44M | $38M | $29M | $12M | $8M | $10M | |
| Common Stock | $4.0K | $4.0K | $3.0K | $2.0K | $2.0K | $2.0K | $1.0K | |
| Paid-in Capital | $1.17B | $1.14B | $714M | $506M | $367M | $327M | $203.0K | |
| Retained Earnings | $-482M | $-569M | $-381M | $-228M | $-124M | $-65M | $-20M | |
| Treasury Stock | $385M | $0 | · | · | · | · | · | |
| Stockholders' Equity | $303M | $572M | $332M | $277M | $243M | $262M | $-19M | |
| Liabilities + Equity | $338M | $616M | $370M | $307M | $255M | $269M | $11M | |
| Shares Outstanding | 19,543,706 | 40,554,705 | 31,841,084 | 27,543,453 | 23,974,834 | 23,192,866 | 2,429,705 |
Cash Flow 12
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $29M | $35M | $29M | $19M | $12M | $4M | $59.0K | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Operating Cash Flow | $108M | $-161M | $-125M | $-70M | $-62M | $-37M | $-16M | |
| CapEx | $2M | $2M | $2M | $1M | $1M | $294.0K | $271.0K | |
| Investing Cash Flow | $-2M | $-2M | $-2M | $-1M | $-1M | $-294.0K | $-271.0K | |
| Stock Issued | · | · | · | · | · | $141M | $0 | |
| Stock Repurchased | $375M | $0 | · | · | · | · | · | |
| Net Stock Activity | $-375M | · | · | · | · | $141M | · | |
| Financing Cash Flow | $-378M | $392M | $179M | $120M | $29M | $296M | $14.0K | |
| Net Change in Cash | $-273M | $229M | $52M | $49M | $-35M | $259M | $-16M | |
| Taxes Paid | $7M | $0 | · | · | · | $0 | $256.0K | |
| Free Cash Flow | $106M | $-163M | $-127M | $-71M | $-63M | $-37M | · |
Profitability 7
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 27.7% | -5939.0% | -112543.7% | · | -280.5% | · | · | |
| Net Margin | 35.7% | -5277.6% | -101319.2% | · | -292.3% | · | · | |
| Pretax Margin | 37.7% | -5269.1% | -101319.2% | · | -282.2% | · | · | |
| EBITDA Margin | 27.7% | -5939.0% | -112543.7% | · | -280.5% | · | · | |
| ROA | 18.2% | -38.0% | -45.2% | -37.2% | -22.4% | -32.4% | · | |
| ROE | 17.2% | -33.9% | -48.7% | -40.4% | -25.4% | -23.1% | · | |
| ROIC | 21.1% | -37.0% | -51.1% | -41.4% | -24.0% | -17.8% | · |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 15.5 | 21.5 | 14.2 | 17.3 | 21.2 | 37.3 | · | |
| Quick Ratio | 14.3 | 20.5 | 13.6 | 16.9 | 20.9 | 37.0 | · |
Efficiency 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | · | |
| Receivables Turnover | 77.3 | 2.5 | 2.1 | 0.0 | 2.2 | · | · |
Valuation (TTM) 10
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $244M | $0 | $151.0K | $0 | $20M | $0 | · | |
| Net Income TTM | $87M | $-187M | $-153M | $-105M | $-59M | $-45M | · | |
| Market Cap | $398M | $642M | $1.27B | $1.32B | $1.40B | $1.64B | · | |
| P/E | 8.9 | -3.2 | -7.6 | -11.6 | -23.2 | -24.1 | · | |
| P/S | 1.6 | · | 8384.1 | · | 69.8 | · | · | |
| P/B | 1.3 | 1.1 | 3.8 | 4.8 | 5.8 | 6.3 | · | |
| P / Tangible Book | 1.3 | 1.1 | 3.8 | 4.8 | 5.8 | 6.3 | · | |
| P / Cash Flow | 3.7 | -4.0 | -10.2 | -18.9 | -22.6 | -44.3 | · | |
| P / FCF | 3.8 | -3.9 | -10.0 | -18.5 | -22.2 | -44.0 | · | |
| Earnings Yield | 11.3% | -31.6% | -13.1% | -8.6% | -4.3% | -4.2% | · |
Income Statement 14
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $32.0K | $380.0K | $14M | $18M | $211M | $0 | $0 | $0 | $0 | $143.0K | $8.0K | $0 | $0 | $0 | $0 | |
| R&D Expense | $22M | $16M | $18M | $20M | $44M | $49M | $46M | $49M | $41M | $38M | $37M | $34M | $33M | $31M | $25M | $21M | |
| SG&A Expense | $9M | $10M | $12M | $10M | $14M | $10M | $11M | $10M | $10M | $10M | $9M | $9M | $9M | $8M | $7M | $7M | |
| Operating Expenses | $31M | $26M | $30M | $30M | $58M | $59M | $56M | $59M | $50M | $49M | $47M | $43M | $41M | $39M | $32M | $28M | |
| Operating Income | $-31M | $-26M | $-29M | $-15M | $-40M | $152M | $-53M | $-59M | $-50M | $-48M | $-46M | $-43M | $-41M | $-39M | $-32M | $-28M | |
| Other Non-op | $-60.0K | $-166.0K | $273.0K | $-253.0K | $-221.0K | $-338.0K | $-229.0K | $-92.0K | $-196.0K | $-437.0K | $56.0K | $-67.0K | $-155.0K | $-40.0K | $-1M | $762.0K | |
| Pretax Income | $-29M | $-24M | $-25M | $-9M | $-33M | $158M | $-46M | $-53M | $-45M | $-43M | · | · | · | · | $-30M | $-24M | |
| Income Tax | $0 | $0 | $-2M | $-1M | $-2M | $10M | $300.0K | $0 | $0 | $0 | · | · | · | · | $0 | $0 | |
| Net Income | $-29M | $-24M | $-23M | $-7M | $-31M | $148M | $-46M | $-53M | $-45M | $-43M | $-40M | $-39M | $-38M | $-36M | $-30M | $-24M | |
| EPS (Basic) | $-1.45 | $-1.21 | $-0.38 | $-0.18 | $-0.76 | $3.66 | $-1.13 | $-1.41 | $-1.25 | $-1.21 | $-1.34 | $-1.33 | $-1.27 | $-1.26 | $-1.09 | $-0.92 | |
| EPS (Diluted) | $-1.45 | $-1.21 | $-0.38 | $-0.18 | $-0.76 | $3.62 | $-1.13 | $-1.41 | $-1.25 | $-1.21 | $-1.34 | $-1.33 | $-1.27 | $-1.26 | $-1.09 | $-0.92 | |
| Shares (Basic) | 19,800,322 | 19,629,906 | -84,574,415 | 40,623,364 | 40,612,907 | 40,559,355 | -71,941,684 | 37,590,727 | 36,103,187 | 35,685,422 | -58,193,039 | 29,668,247 | 29,602,458 | 28,369,453 | -48,356,346 | 25,549,701 | |
| Shares (Diluted) | 19,800,322 | 19,629,906 | -84,398,490 | 40,623,364 | 40,612,907 | 41,021,325 | -71,941,684 | 37,590,727 | 36,103,187 | 35,685,422 | -58,193,039 | 29,668,247 | 29,602,458 | 28,369,453 | -48,356,346 | 25,549,701 | |
| EBITDA | $-31M | $-26M | · | $-15M | $-40M | $152M | · | $-59M | $-50M | $-48M | · | $-43M | $-41M | $-39M | · | $-28M |
Balance Sheet 22
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $258M | $281M | $287M | $693M | $690M | $721M | $560M | $531M | $406M | $442M | $331M | $288M | $322M | $351M | $279M | $239M | |
| Receivables | $0 | $400.0K | $4M | $3M | $16M | $17M | $3M | $388.0K | $4.0K | $226.0K | $143.0K | · | · | · | · | $0 | |
| Prepaid Expense | $7M | $7M | $22M | $22M | $27M | $22M | $26M | $21M | $27M | $20M | $16M | $17M | $12M | $11M | · | $6M | |
| Other Current Assets | $760.0K | $1M | $2M | $3M | $3M | $3M | $1M | $1M | $582.0K | $616.0K | $1M | $319.0K | $376.0K | $515.0K | · | $745.0K | |
| Current Assets | $267M | $291M | $315M | $719M | $733M | $760M | $589M | $552M | $433M | $463M | $347M | $304M | $334M | $362M | · | $246M | |
| PP&E (Net) | $4M | $4M | $4M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | · | $2M | |
| PP&E (Gross) | · | · | $9M | · | · | · | $7M | · | · | · | $6M | · | · | · | · | · | |
| Accum. Depreciation | · | · | $4M | · | · | · | $3M | · | · | · | $2M | · | · | · | · | · | |
| Other Non-current Assets | · | · | $0 | $0 | $0 | $463.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $3M | |
| Total Assets | $288M | $312M | $338M | $743M | $757M | $785M | $616M | $579M | $455M | $486M | $370M | $326M | $356M | $384M | · | $253M | |
| Accounts Payable | $2M | $1M | $2M | $2M | $5M | $7M | $5M | $5M | $7M | $5M | $5M | $4M | $4M | $5M | · | $3M | |
| Accrued Liabilities | $8M | $9M | $16M | $15M | $20M | $17M | $21M | $22M | $14M | $13M | $18M | $12M | $12M | $11M | · | $8M | |
| Current Liabilities | $12M | $13M | $20M | $24M | $35M | $39M | $27M | $29M | $21M | $19M | $24M | $17M | $16M | $15M | · | $12M | |
| Capital Leases | $13M | $14M | $14M | $15M | $16M | $16M | $17M | $17M | $13M | $13M | $13M | $14M | $14M | $14M | · | $0 | |
| Total Liabilities | $25M | $27M | $35M | $39M | $50M | $56M | $44M | $46M | $34M | $32M | $38M | $30M | $30M | $29M | · | $12M | |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | · | $2.0K | |
| Paid-in Capital | $1.18B | $1.18B | $1.17B | $1.16B | $1.16B | $1.15B | $1.14B | $1.06B | $891M | $878M | $714M | $637M | $628M | $619M | · | $440M | |
| Retained Earnings | $-534M | $-505M | $-482M | $-458M | $-451M | $-420M | $-569M | $-523M | $-470M | $-425M | $-381M | $-341M | $-302M | $-264M | · | $-199M | |
| Treasury Stock | $385M | $385M | $385M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $262M | $286M | $303M | $704M | $707M | $729M | $572M | $533M | $421M | $454M | $332M | $296M | $326M | $355M | $277M | $241M | |
| Liabilities + Equity | $288M | $312M | $338M | $743M | $757M | $785M | $616M | $579M | $455M | $486M | $370M | $326M | $356M | $384M | · | $253M | |
| Shares Outstanding | 19,827,188 | 19,732,837 | 19,543,706 | 40,632,164 | 40,615,414 | 40,562,047 | 40,554,705 | 39,258,476 | 36,169,558 | 36,067,786 | 31,841,084 | 29,679,143 | 29,661,005 | 29,548,649 | · | 26,077,204 |
Cash Flow 9
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $6M | $7M | $4M | $9M | $9M | $9M | $9M | $9M | $8M | $7M | $9M | $7M | $6M | $5M | $5M | |
| Operating Cash Flow | $-20M | $-4M | $-27M | $3M | $-30M | $161M | $-46M | $-30M | $-40M | $-45M | $-25M | $-34M | $-31M | $-34M | $-21M | $-25M | |
| CapEx | $155.0K | $73.0K | $134.0K | $132.0K | $720.0K | $565.0K | $289.0K | $386.0K | $310.0K | $946.0K | $541.0K | $550.0K | $311.0K | $1M | $351.0K | $176.0K | |
| Investing Cash Flow | $-155.0K | $-73.0K | $-134.0K | $-132.0K | $-720.0K | $-565.0K | $-289.0K | $-386.0K | $-310.0K | $-946.0K | $-541.0K | $-550.0K | $-311.0K | $-1M | $-351.0K | $-176.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | $151M | · | $0 | $0 | $107M | · | $48M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $151M | · | · | · | $107M | · | · | |
| Financing Cash Flow | $-3M | $-2M | $-379M | $140.0K | $17.0K | $4.0K | $76M | $156M | $4M | $157M | $69M | $284.0K | $2M | $108M | $61M | $49M | |
| Net Change in Cash | $-24M | $-6M | $-406M | $3M | $-30M | $161M | $29M | $125M | $-37M | $111M | $43M | $-34M | $-29M | $72M | $40M | $24M | |
| Free Cash Flow | · | $-4M | · | · | · | $161M | · | · | · | $-46M | · | · | · | $-35M | · | · |
Profitability 7
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -80865.6% | · | -108.9% | -219.2% | 72.0% | · | -15117.8% | -136321.6% | -58413.3% | · | -541000.0% | · | · | · | · | |
| Net Margin | · | -74087.5% | · | -51.5% | -169.0% | 70.3% | · | -13648.4% | -122316.2% | -51944.6% | · | -493000.0% | · | · | · | · | |
| Pretax Margin | · | -74087.5% | · | -61.6% | -181.2% | 75.0% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | · | -80865.6% | · | -108.9% | -219.2% | 72.0% | · | -15117.8% | -136321.6% | -58413.3% | · | -541000.0% | · | · | · | · | |
| ROA | -5.5% | -4.3% | · | -1.1% | -5.1% | 23.4% | · | -11.7% | -11.2% | -9.9% | · | -13.6% | -12.9% | -11.6% | · | -9.7% | |
| ROE | -5.9% | -4.7% | · | -1.2% | -5.4% | 25.1% | · | -12.8% | -12.1% | -10.7% | · | -14.7% | -14.0% | -12.4% | · | -10.2% | |
| ROIC | -11.8% | -9.1% | · | -1.8% | -5.2% | 19.5% | · | · | · | · | · | · | · | · | · | -11.6% |
Liquidity & Solvency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 22.0 | 22.6 | · | 29.9 | 21.1 | 19.3 | · | 19.0 | 20.4 | 24.7 | · | 18.2 | 20.8 | 23.4 | · | 21.3 | |
| Quick Ratio | 21.2 | 21.9 | · | 28.9 | 20.3 | 18.7 | · | 18.3 | 19.1 | 23.6 | · | 17.2 | 20.0 | 22.7 | · | 20.8 |
Efficiency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.3 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · | · | 0.0 | |
| Receivables Turnover | 0.0 | 0.0 | · | 7.3 | 2.3 | 24.1 | · | 2.0 | 18.5 | 0.7 | · | · | · | · | · | · |
Valuation (TTM) 10
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $32M | $244M | · | $243M | $229M | $211M | · | $8.0K | $8.0K | $8.0K | · | $8.0K | $0 | · | · | · | |
| Net Income TTM | $-90M | $87M | · | $58M | $20M | $7M | · | $-181M | $-165M | $-156M | · | $-136M | $-124M | $-111M | · | $-95M | |
| Market Cap | $212M | $218M | · | $643M | $542M | $413M | · | $2.28B | $1.65B | $2.39B | · | $946M | $1.19B | $1.26B | · | $981M | |
| P/E | -3.0 | 7.5 | · | 12.5 | 66.8 | -40.8 | · | -11.2 | -9.0 | -13.1 | · | -6.7 | -8.8 | -9.9 | · | -9.6 | |
| P/S | 6.6 | 0.9 | · | 2.6 | 2.4 | 2.0 | · | 284967.5 | 206618.6 | 298460.9 | · | 118271.4 | · | · | · | · | |
| P/B | 0.8 | 0.8 | · | 0.9 | 0.8 | 0.6 | · | 4.3 | 3.9 | 5.3 | · | 3.2 | 3.7 | 3.6 | · | 4.1 | |
| P / Tangible Book | 0.8 | 0.8 | · | 0.9 | 0.8 | 0.6 | · | 4.3 | 3.9 | 5.3 | · | 3.2 | 3.7 | 3.6 | · | 4.1 | |
| P / Cash Flow | · | -61.7 | · | · | · | 2.6 | · | · | · | -53.6 | · | · | · | -36.9 | · | · | |
| P / FCF | · | -60.5 | · | · | · | 2.6 | · | · | · | -52.5 | · | · | · | -35.7 | · | · | |
| Earnings Yield | -33.6% | 13.3% | · | 8.0% | 1.5% | -2.5% | · | -8.9% | -11.1% | -7.7% | · | -15.0% | -11.4% | -10.1% | · | -10.4% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | $244M | $0 | $151.0K | $0 | $20M |
| Operating Margin % | 27.7% | -5939.0% | -112543.7% | — | -280.5% |
| Net Income | $87M | $-187M | $-153M | $-105M | $-59M |
| Diluted EPS | $2.30 | $-5.00 | $-5.20 | $-4.15 | $-2.52 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Current Ratio | 15.5 | 21.5 | 14.2 | 17.3 | 21.2 |
| Quick Ratio | 14.3 | 20.5 | 13.6 | 16.9 | 20.9 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | $106M | $-163M | $-127M | $-71M | $-63M |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 149 filers · $142.4M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 21 (-5 vs prior Q) | 29 (-6 vs prior Q) | 42 (-3 vs prior Q) | 46 (-8 vs prior Q) | +595K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | $15,091,483 | 1,410,419 | 10.60% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $8,919,477 | 833,596 | 6.26% | Shares |
| ORBIMED ADVISORS LLC | $8,122,959 | 759,155 | 5.71% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6,983,195 | 652,635 | 4.90% | Shares |
| MACKENZIE FINANCIAL CORP | $6,724,287 | 628,438 | 4.72% | Shares |
| Madison Avenue Partners, LP | $6,704,438 | 626,583 | 4.71% | Shares |
| Qube Research & Technologies Ltd | $6,514,556 | 608,837 | 4.58% | Shares |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $6,478,262 | 605,445 | 4.55% | Shares |
| STATE STREET CORP | $5,790,765 | 541,193 | 4.07% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $4,694,194 | 438,563 | 3.30% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $4,526,357 | 423,024 | 3.18% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $3,842,220 | 359,086 | 2.70% | Shares |
| TWO SIGMA ADVISERS, LP | $3,497,848 | 171,800 | 2.46% | Shares |
| CITADEL ADVISORS LLC | $3,095,435 | 289,293 | 2.17% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $2,835,682 | 265,017 | 1.99% | Shares |
| BlackRock, Inc. | $2,790,421 | 260,787 | 1.96% | Shares |
| ADAR1 Capital Management, LLC | $2,640,953 | 246,818 | 1.85% | Shares |
| TWO SIGMA INVESTMENTS, LP | $2,639,144 | 246,649 | 1.85% | Shares |
| VANGUARD GROUP INC | $2,594,882 | 127,450 | 1.82% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $2,494,973 | 233,175 | 1.75% | Shares |
| MILLENNIUM MANAGEMENT LLC | $1,977,595 | 184,822 | 1.39% | Shares |
| Cubist Systematic Strategies, LLC | $1,922,605 | 121,530 | 1.35% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,698,218 | 158,712 | 1.19% | Shares |
| Man Group plc | $1,664,289 | 155,541 | 1.17% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $1,405,060 | 131,314 | 0.99% | Shares |
| Connor, Clark & Lunn Investment Management Ltd. | $1,368,370 | 127,885 | 0.96% | Shares |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $1,352,255 | 126,379 | 0.95% | Shares |
| Nebula Research & Development LLC | $1,206,920 | 90,406 | 0.85% | Shares |
| AMERIPRISE FINANCIAL INC | $1,084,360 | 101,342 | 0.76% | Shares |
| GOLDMAN SACHS GROUP INC | $942,221 | 88,058 | 0.66% | Shares |
| AMERICAN CENTURY COMPANIES INC | $906,076 | 84,680 | 0.64% | Shares |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $902,781 | 84,372 | 0.63% | Shares |
| HSBC HOLDINGS PLC | $761,494 | 69,926 | 0.53% | Shares |
| MARTINGALE ASSET MANAGEMENT L P | $725,418 | 67,796 | 0.51% | Shares |
| RBF Capital, LLC | $671,960 | 62,800 | 0.47% | Shares |
| AlphaQuest LLC | $653,352 | 32,090 | 0.46% | Shares |
| Bank of New York Mellon Corp | $646,869 | 60,455 | 0.45% | Shares |
| XTX Topco Ltd | $636,982 | 59,531 | 0.45% | Shares |
| Jain Global LLC | $633,536 | 59,209 | 0.44% | Shares |
| PANAGORA ASSET MANAGEMENT INC | $599,040 | 55,985 | 0.42% | Shares |
| IEQ CAPITAL, LLC | $595,723 | 55,675 | 0.42% | Shares |
| JANE STREET GROUP, LLC | $583,557 | 54,538 | 0.41% | Shares |
| Rangeley Capital, LLC | $582,080 | 54,400 | 0.41% | Shares |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $538,467 | 50,324 | 0.38% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $533,406 | 49,851 | 0.37% | Shares |
| Y-Intercept (Hong Kong) Ltd | $515,483 | 48,176 | 0.36% | Shares |
| BARCLAYS PLC | $509,576 | 47,624 | 0.36% | Shares |
| DEUTSCHE BANK AG\ | $500,781 | 46,802 | 0.35% | Shares |
| Susquehanna Portfolio Strategies, LLC | $479,617 | 44,824 | 0.34% | Shares |
| Mariner, LLC | $416,218 | 38,895 | 0.29% | Shares |
| D. E. Shaw & Co., Inc. | $386,602 | 36,131 | 0.27% | Shares |
| FMR LLC | $378,010 | 35,328 | 0.27% | Shares |
| PRELUDE CAPITAL MANAGEMENT, LLC | $374,917 | 35,039 | 0.26% | Shares |
| MARSHALL WACE, LLP | $370,220 | 34,600 | 0.26% | Shares |
| ALLIANCEBERNSTEIN L.P. | $366,528 | 33,200 | 0.26% | Shares |
| RHUMBLINE ADVISERS | $350,471 | 32,755 | 0.25% | Shares |
| BANK OF AMERICA CORP /DE/ | $334,161 | 31,230 | 0.23% | Shares |
| Squarepoint Ops LLC | $333,883 | 31,204 | 0.23% | Shares |
| MERCER GLOBAL ADVISORS INC /ADV | $296,219 | 27,684 | 0.21% | Shares |
| Quantinno Capital Management LP | $288,590 | 26,971 | 0.20% | Shares |
| Advantage Alpha Capital Partners LP | $285,693 | 18,059 | 0.20% | Shares |
| FEDERATED HERMES, INC. | $268,153 | 25,061 | 0.19% | Shares |
| CANADA PENSION PLAN INVESTMENT BOARD | $247,170 | 23,100 | 0.17% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $225,160 | 21,043 | 0.16% | Shares |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $210,524 | 17,841 | 0.15% | Shares |
| MORGAN STANLEY | $188,518 | 17,618 | 0.13% | Shares |
| Creative Planning | $178,776 | 16,708 | 0.13% | Shares |
| MetLife Investment Management, LLC | $178,497 | 16,682 | 0.13% | Shares |
| Empowered Funds, LLC | $177,984 | 16,634 | 0.13% | Shares |
| WELLS FARGO & COMPANY/MN | $165,636 | 15,480 | 0.12% | Shares |
| Jump Financial, LLC | $164,780 | 15,400 | 0.12% | Shares |
| EJF Capital LP | $160,500 | 15,000 | 0.11% | Shares |
| EDBI Pte Ltd | $159,962 | 10,105 | 0.11% | Shares |
| CITADEL ADVISORS LLC | $154,080 | 14,400 | 0.11% | Put option |
| nVerses Capital, LLC | $140,426 | 13,124 | 0.10% | Shares |
| Cerity Partners LLC | $136,308 | 12,739 | 0.10% | Shares |
| Engineers Gate Manager LP | $130,701 | 12,215 | 0.09% | Shares |
| PDT Partners, LLC | $122,034 | 11,405 | 0.09% | Shares |
| Point72 Asset Management, L.P. | $111,205 | 10,393 | 0.08% | Shares |
| AMERICAN FINANCIAL GROUP INC | $108,124 | 10,105 | 0.08% | Shares |
| Arax Advisory Partners | $107,503 | 10,047 | 0.08% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $97,541 | 9,116 | 0.07% | Shares |
| CWM, LLC | $95,143 | 8,618 | 0.07% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $91,068 | 8,511 | 0.06% | Shares |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $85,311 | 7,973 | 0.06% | Shares |
| CITIGROUP INC | $85,044 | 7,948 | 0.06% | Shares |
| Vanguard Global Advisers, LLC | $85,012 | 7,945 | 0.06% | Shares |
| Police & Firemen's Retirement System of New Jersey | $82,390 | 7,700 | 0.06% | Shares |
| Invesco Ltd. | $81,170 | 7,586 | 0.06% | Shares |
| JPMORGAN CHASE & CO | $75,865 | 6,941 | 0.05% | Shares |
| NISA INVESTMENT ADVISORS, LLC | $42,682 | 3,989 | 0.03% | Shares |
| China Universal Asset Management Co., Ltd. | $33,705 | 3,150 | 0.02% | Shares |
| IFP Advisors, Inc | $32,239 | 3,013 | 0.02% | Shares |
| NORTHERN TRUST CORP | $30,977 | 2,895 | 0.02% | Shares |
| Ameritas Investment Partners, Inc. | $25,380 | 2,372 | 0.02% | Shares |
| OSAIC HOLDINGS, INC. | $21,421 | 2,002 | 0.02% | Shares |
| Tower Research Capital LLC (TRC) | $21,036 | 1,966 | 0.01% | Shares |
| Legal & General Group Plc | $20,747 | 1,939 | 0.01% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $19,795 | 1,850 | 0.01% | Shares |
| Point72 Asia (Singapore) Pte. Ltd. | $19,554 | 1,236 | 0.01% | Shares |
Company insiders 17 insiders · 6 officers · 12 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Jasbir Seehra | Chief Executive Officer | April 8, 2023 M | 252,856 | 0 | 0 | $0 |
| Keith Regnante | Chief Financial Officer | Jan. 4, 2024 M | 0 | 0 | 0 | $0 |
| Christopher Rovaldi | Chief Operating Officer | Feb. 16, 2023 A | 0 | 0 | 0 | $0 |
| Simon Peter Cooper | Chief Medical Officer | Feb. 16, 2023 A | — | 0 | 0 | $0 |
| Jennifer Lachey | Chief Scientific Officer | July 15, 2022 M | 95,100 | 0 | 0 | $0 |
| Claudia Ordonez | Chief Medical Officer | June 11, 2021 M | 0 | 0 | 0 | $0 |
| Jean Jacques Bienaime | Director | July 15, 2026 P | 18,592 | 5 | 0 | $65,500 |
| Anne Prener | Director | July 1, 2026 A | 13,786 | 0 | 0 | $0 |
| Charles W. Newton | Director | June 11, 2026 S | 12,665 | 0 | 1 | $-5,522 |
| Julius Knowles | Director | June 4, 2026 S | 10,958 | 0 | 1 | $-28,166 |
| Nima Farzan | Director | June 4, 2026 S | 9,767 | 0 | 1 | $-28,166 |
| Alpna Seth | Director | June 4, 2026 S | 9,767 | 0 | 1 | $-28,140 |
| Mary Ann Gray | Director | June 3, 2026 A | 12,392 | 0 | 0 | $0 |
| GORDON CARL L | Director | Nov. 21, 2025 D | 45,057 | 0 | 0 | $0 |
| Ran Nussbaum | Director | June 6, 2023 A | 1,226,412 | 0 | 0 | $0 |
| Tomer Kariv | Director | June 6, 2023 A | 1,226,412 | 0 | 0 | $0 |
| Alon Lazarus | Director | April 13, 2020 C | 2,013,102 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 4 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Pontifax Management 4 GP (2015) Ltd., Pontifax (Israel) IV, L.P., Pontifax (Cayman) IV, L.P., Pontifax (China) IV, L.P., Pontifax Late Stage Fund L.P., Pontifax Late Stage GP Ltd. ×3 filings | Oct. 16, 2025 | 0.00% | Amendment | — | SEC |
| ADAR1 Capital Management, LLC, ADAR1 Capital Management GP, LLC, Daniel Schneeberger ×6 filings | Oct. 15, 2025 | 0.00% | Amendment | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC, OrbiMed Capital LLC ×4 filings | Dec. 13, 2023 | — | Initial filing | — | SEC |
| Arkin Bio Ventures Limited Partnership, Arkin Bio Venture Partners Ltd., Moshe Arkin, Alon Lazarus ×3 filings | Dec. 17, 2020 | — | Initial filing | Board campaign | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 37 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0.38% | 12,830 NS | April 30, 2026 | N-PORT |
| OASC · Unified Series Trust | 0.20% | 15,034 NS | May 31, 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0.10% | 23,576 NS | May 31, 2026 | N-PORT |
| IWC · iShares Trust | 0.05% | 63,474 SH | Aug. 8, 2026 | Daily |
| GSSC · Goldman Sachs ETF Trust | 0.04% | 38,819 NS | May 31, 2026 | N-PORT |
| SMLF · iShares Trust | 0.03% | 104,137 SH | Aug. 8, 2026 | Daily |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.02% | 6,426 SH | Aug. 8, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.02% | 55,956 SH | Aug. 8, 2026 | Daily |
| VFVA · VANGUARD WELLINGTON FUND | 0.02% | 17,295 SH | Aug. 8, 2026 | Daily |
| SFGV · EA Series Trust | 0.02% | 16,659 NS | May 29, 2026 | N-PORT |
| BIB · ProShares Trust | 0.02% | 1,125 NS | May 31, 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.02% | 1,074 SH | Aug. 8, 2026 | Daily |
| IBB · iShares Trust | 0.01% | 132,792 SH | Aug. 8, 2026 | Daily |
| IWN · iShares Trust | 0.01% | 172,816 SH | Aug. 8, 2026 | Daily |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.01% | 27,974 NS | May 31, 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 106,081 SH | Aug. 8, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 16,122 SH | Aug. 8, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 12,811 NS | April 30, 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.01% | 63,454 NS | April 30, 2026 | N-PORT |
| ITWO · ProShares Trust | 0.01% | 1,375 NS | May 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.01% | 465,257 SH | Aug. 8, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.01% | 65,248 NS | April 30, 2026 | N-PORT |
| UWM · ProShares Trust | 0.00% | 1,075 NS | May 31, 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.00% | 92,945 NS | May 31, 2026 | N-PORT |
| URTY · ProShares Trust | 0.00% | 1,085 NS | May 31, 2026 | N-PORT |
| AVUV · AMERICAN CENTURY ETF TRUST | 0.00% | 83,474 NS | May 31, 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,190 NS | May 31, 2026 | N-PORT |
| HDG · ProShares Trust | 0.00% | 27 NS | May 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 20,827 NS | April 30, 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 7,079 SH | Aug. 8, 2026 | Daily |
| DFAT · Dimensional ETF Trust | 0.00% | 4,070 NS | April 30, 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 11,035 NS | May 31, 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.00% | 1,224 NS | May 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 220,854 SH | Aug. 8, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 595,316 SH | Aug. 8, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 980 SH | Aug. 8, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.00% | 49,290 SH | Aug. 8, 2026 | Daily |